Premier Biomedical, Inc. (OTCMKTS:BIEI – Get Free Report) was the target of a large growth in short interest during the month of October. As of October 30th, there was short interest totaling 39,000 shares. Based on an average daily trading volume, of 16,150,651 shares, the days-to-cover ratio is presently 0.0 days.
Premier Biomedical Stock Performance
Shares of OTCMKTS BIEI remained flat at $0.00 during mid-day trading on Monday. 51,870 shares of the company were exchanged, compared to its average volume of 18,890,506. Premier Biomedical has a 1 year low of $0.00 and a 1 year high of $0.00.
About Premier Biomedical
Premier Biomedical, Inc. is a development-stage biotechnology company focused on researching and developing therapies for serious medical conditions. Its work has included potential treatments for cancer, chronic pain, depression, post-traumatic stress disorder and other diseases. The company has described proprietary approaches involving the selective removal or modification of substances in the blood, as well as drug-delivery technologies intended to improve the administration of therapeutic compounds.
See Also
- Five stocks we like better than Premier Biomedical
- Could Big Buybacks Be the Next Catalyst for These 3 AI Stocks?
- 3 AI Hardware Leaders Are Raising Dividends, But Which Offers More Income?
- Sandisk’s Sell-Off May Be Losing Steam, But the Biggest Risk Still Looms
- Meta’s Access to Capital Remains Strong, But Borrowing Is Becoming More Expensive
Receive News & Ratings for Premier Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Premier Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
